Patents by Inventor Daniel M. Musher

Daniel M. Musher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4146644
    Abstract: A method for the treatment of urinary tract infections and a composition for use in such method, such method comprising administering to a patient suffering from a urinary tract infection an effective anti-bacterial dosage of a composition comprising in combination:A. a source of methenamine, e.g. methenamine; andB. a source of hydroxamate groups, e.g., acetohydroxamic acid.The source of hydroxamate groups is administered in the amount effective to potentiate the anti-bacterial effect of the source of methenamine. The method is specifically applied to the treatment of urinary infections caused by urease producing bacteria, especially bacteria of the species Proteus.In addition, where colonization of the bacteria can be tolerated and where it is only necessary to eliminate the pathogenicity of the urease producing bacteria induced infection, effective treatment can be achieved by administration of only the source of hydroxamate groups, preferably acetohydroxamic acid.
    Type: Grant
    Filed: January 26, 1977
    Date of Patent: March 27, 1979
    Inventors: Donald P. Griffith, Daniel M. Musher
  • Patent number: 4024256
    Abstract: A method for the treatment of urinary tract infections and a composition for use in such method, such method comprising administering to a patient suffering from a urinary tract infection an effective anti-bacterial dosage of a composition comprising in combination:A. a source of methenamine, e.g. methenamine; andB. a source of hydroxamate groups, e.g., acetohydroxamic acid.The source of hydroxamate groups is administered in the amount effective to potentiate the anti-bacterial effect of the source of methenamine. The method is specifically applied to the treatment of urinary infections caused by urease producing bacteria, especially bacteria of the species proteus.In addition, where colonization of the bacteria can be tolerated and where it is only necessary to eliminate the pathogenicity of the urease producing bacteria induced infection, effective treatment can be achieved by administration of only the source of hydroxamate groups, preferably acetohydroxamic acid.
    Type: Grant
    Filed: September 18, 1975
    Date of Patent: May 17, 1977
    Inventors: Donald P. Griffith, Daniel M. Musher